<DOC>
	<DOCNO>NCT01405391</DOCNO>
	<brief_summary>Phase I Study PM01183 Non-Colorectal Cancer Patients determine recommend dose ( RD ) PM01183 .</brief_summary>
	<brief_title>Study PM01183 Non-Colorectal Cancer Patients Days 1 8 Intravenous Short Infusion Every 3 Weeks</brief_title>
	<detailed_description>Phase I Study PM01183 Non-Colorectal ( non-CRC ) Cancer Patients determine recommend dose ( RD ) PM01183 , characterize safety profile , compliance feasibility schedule , optimize individualize PM01183 dose non-CRC patient accord individual tolerance , characterize pharmacokinetics ( PK ) schedule , obtain preliminary information clinical antitumor activity perform exploratory pharmacogenomics ( PGx ) analysis .</detailed_description>
	<criteria>1 . Voluntarily sign date write informed consent 2 . Age ≥ 18 year . 3 . Non minimally daily activitiesinterfering disease relate symptom . 4 . Life expectancy ≥ 3 month . 5 . Patients solid tumor CRC . 6 . Adequate bone marrow , renal , hepatic , metabolic function ( test within normal limit minimally alter assessed ≤ 7 day inclusion study ) Recovery asymptomatic minimally altered baseline adverse event ( AE ) derive previous treatment ( mild alteration alopecia , skin toxicity fatigue allow ) . 7 . Normal cardiac function cardiac function appropriate image test . 8 . Women childbearing potential must negative serum pregnancy test study entry . 1 . Primary colorectal cancer diagnosis 2 . Prior treatment PM01183 . 3 . Concomitant diseases/conditions : ) History clinically relevant cardiac condition c ) Known chronic liver disease . ) Active uncontrolled infection . e ) Known human immunodeficiency virus ( HIV ) infection . f ) Limitation patient 's ability comply treatment followup protocol . 4 . Symptomatic progressive corticosteroidrequiring document brain metastasis 5 . Men woman childbearing potential use effective method contraception previously describe ; woman pregnant breast feeding . 6 . History extensive prior pelvic irradiation . 7 . History previous bone marrow and/or stem cell transplantation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Pharma Mar</keyword>
	<keyword>PM01183</keyword>
	<keyword>Non-Colorectal Cancer ( non-CRC )</keyword>
	<keyword>Dose find phase I</keyword>
</DOC>